• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估一种针对不同抗原性 H9N2 流感病毒的商业疫苗在鸡中的保护效力。

Evaluation of the protective efficacy of a commercial vaccine against different antigenic groups of H9N2 influenza viruses in chickens.

机构信息

Key Laboratory of Animal Epidemiology and Zoonosis, Ministry of Agriculture, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.

出版信息

Vet Microbiol. 2012 Apr 23;156(1-2):193-9. doi: 10.1016/j.vetmic.2011.10.003. Epub 2011 Oct 10.

DOI:10.1016/j.vetmic.2011.10.003
PMID:22019289
Abstract

Despite the long-term vaccination programs implemented in China, H9N2 avian influenza viruses (AIVs) continue to persist in chicken populations, even in vaccinated flocks. We previously demonstrated that H9N2 AIV isolated from chickens in China also underwent antigenic drift and evolved into distinct antigenic groups (C, D and E). To understand whether antigenic drift of viruses away from the vaccine strain partially contributed to the circulation of H9N2 AIV in China, we evaluated the protective efficacy of a commercial vaccine against different antigenic groups of H9N2 AIV. Challenge experiments using vaccinated chickens indicated that the vaccine prevented shedding of antigenic group C viruses, but not those of the more recent groups D and E. Vaccinated chickens, even those with vaccine-induced HI titers of 1:1024, shed virus after being infected with A/chicken/Shandong/ZB/2007, a representative virus of antigenic group D. Genetic analysis showed that the representative viruses of antigenic groups D and E possessed greater numbers of amino acid substitutions in the hemagglutinin protein compared to the vaccine strain and the antigenic group C virus, and many of which were located in antigenic sites. Our results indicated that the persistence of H9N2 AIV in China might be due to incomplete vaccine protection, and that the avian influenza vaccine should be regularly evaluated and updated to maintain optimal protection. Furthermore, the avian influenza vaccination policy also needs to be re-assessed, and increased veterinary biosecurity on farms, rather than vaccine application alone, should be implemented to prevent and control avian influenza.

摘要

尽管中国实施了长期的疫苗接种计划,但 H9N2 禽流感病毒(AIV)仍在鸡群中持续存在,即使是在接种过疫苗的禽类中。我们之前已经证明,从中国鸡群中分离出的 H9N2 AIV 也发生了抗原漂移,并进化成了不同的抗原群(C、D 和 E)。为了了解病毒的抗原漂移是否部分导致了 H9N2 AIV 在我国的传播,我们评估了一种商业疫苗对不同抗原群 H9N2 AIV 的保护效果。用接种疫苗的鸡进行的攻毒实验表明,该疫苗可以预防抗原群 C 病毒的脱落,但不能预防最近出现的抗原群 D 和 E 病毒的脱落。接种疫苗的鸡,即使其 HI 滴度达到 1:1024,在感染了抗原群 D 的代表病毒 A/chicken/Shandong/ZB/2007 后仍会脱落病毒。遗传分析表明,抗原群 D 和 E 的代表病毒在血凝素蛋白上具有比疫苗株和抗原群 C 病毒更多的氨基酸替换,其中许多位于抗原位点。我们的结果表明,H9N2 AIV 在我国的持续存在可能是由于疫苗保护不完全,因此需要定期评估和更新禽流感疫苗,以保持最佳保护效果。此外,还需要重新评估禽流感疫苗接种政策,并在农场实施更严格的兽医生物安全措施,而不仅仅是疫苗接种,以预防和控制禽流感。

相似文献

1
Evaluation of the protective efficacy of a commercial vaccine against different antigenic groups of H9N2 influenza viruses in chickens.评估一种针对不同抗原性 H9N2 流感病毒的商业疫苗在鸡中的保护效力。
Vet Microbiol. 2012 Apr 23;156(1-2):193-9. doi: 10.1016/j.vetmic.2011.10.003. Epub 2011 Oct 10.
2
Genotypic evolution and antigenicity of H9N2 influenza viruses in Shanghai, China.中国上海H9N2流感病毒的基因型进化与抗原性
Arch Virol. 2016 Jun;161(6):1437-45. doi: 10.1007/s00705-016-2767-1. Epub 2016 Mar 3.
3
Antigenic evolution of H9N2 chicken influenza viruses isolated in China during 2009-2013 and selection of a candidate vaccine strain with broad cross-reactivity.2009 - 2013年中国分离的H9N2鸡流感病毒的抗原进化及具有广泛交叉反应性的候选疫苗株的筛选
Vet Microbiol. 2016;182:1-7. doi: 10.1016/j.vetmic.2015.10.031. Epub 2015 Nov 2.
4
Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.一种针对新城疫和H9N2禽流感流行毒株的灭活二价疫苗的效力
Virol J. 2017 Mar 16;14(1):56. doi: 10.1186/s12985-017-0723-7.
5
Molecular and antigenic characterization of H9N2 avian influenza virus isolates from chicken flocks between 1998 and 2007 in China.1998 年至 2007 年间中国鸡群中分离的 H9N2 禽流感病毒的分子和抗原特征。
Vet Microbiol. 2012 May 4;156(3-4):285-93. doi: 10.1016/j.vetmic.2011.11.014. Epub 2011 Nov 28.
6
Genetic and antigenic evolution of H9N2 subtype avian influenza virus in domestic chickens in southwestern China, 2013-2016.2013 - 2016年中国西南部家鸡中H9N2亚型禽流感病毒的遗传与抗原进化
PLoS One. 2017 Feb 3;12(2):e0171564. doi: 10.1371/journal.pone.0171564. eCollection 2017.
7
Molecular and Antigenic Characterization of Avian H9N2 Viruses in Southern China.中国南方地区禽 H9N2 病毒的分子和抗原特征。
Microbiol Spectr. 2022 Feb 23;10(1):e0082221. doi: 10.1128/spectrum.00822-21. Epub 2022 Jan 12.
8
Enhanced cross-lineage protection induced by recombinant H9N2 avian influenza virus inactivated vaccine.重组 H9N2 禽流感病毒灭活疫苗诱导的增强型跨谱系保护。
Vaccine. 2019 Mar 22;37(13):1736-1742. doi: 10.1016/j.vaccine.2019.02.012. Epub 2019 Feb 20.
9
Protection of chickens against H9N2 avian influenza virus challenge with recombinant Lactobacillus plantarum expressing conserved antigens.用表达保守抗原的重组植物乳杆菌保护鸡免受H9N2禽流感病毒攻击
Appl Microbiol Biotechnol. 2017 Jun;101(11):4593-4603. doi: 10.1007/s00253-017-8230-8. Epub 2017 Mar 29.
10
Generation and protective efficacy of a cold-adapted attenuated avian H9N2 influenza vaccine.一种冷适应减毒禽H9N2流感疫苗的产生及其保护效力
Sci Rep. 2016 Jul 26;6:30382. doi: 10.1038/srep30382.

引用本文的文献

1
Construction of a replication-defective recombinant virus and cell-based vaccine for H9N2 avian influenza virus.构建针对H9N2禽流感病毒的复制缺陷型重组病毒和基于细胞的疫苗。
Vet Res. 2025 Jul 8;56(1):144. doi: 10.1186/s13567-025-01577-x.
2
Naringenin as a phytogenic adjuvant systematically enhances the protective efficacy of H9N2 inactivated vaccine through coordinated innate-adaptive immune priming in chickens.柚皮素作为一种植物源佐剂,通过协调鸡体内先天性-适应性免疫启动,系统性增强H9N2灭活疫苗的保护效力。
Poult Sci. 2025 Aug;104(8):105257. doi: 10.1016/j.psj.2025.105257. Epub 2025 May 2.
3
Impact of inactivated vaccine on transmission and evolution of H9N2 avian influenza virus in chickens.
灭活疫苗对鸡群中H9N2禽流感病毒传播及进化的影响
NPJ Vaccines. 2025 Apr 4;10(1):67. doi: 10.1038/s41541-025-01115-y.
4
Spray vaccination with a safe and bivalent H9N2 recombinant chimeric NDV vector vaccine elicits complete protection against NDV and H9N2 AIV challenge.用安全的二价H9N2重组嵌合新城疫病毒(NDV)载体疫苗进行喷雾免疫接种,可引发针对新城疫病毒和H9N2禽流感病毒(AIV)攻击的完全保护作用。
Vet Res. 2025 Jan 31;56(1):24. doi: 10.1186/s13567-025-01448-5.
5
The inhibitory effect of Hypericum japonicum on H9N2 avian influenza virus.地耳草对H9N2禽流感病毒的抑制作用。
Adv Biotechnol (Singap). 2024 Nov 6;2(4):41. doi: 10.1007/s44307-024-00046-4.
6
Construction and Immunogenicity Evaluation of Recombinant Bacillus subtilis Expressing HA1 Protein of H9N2 Avian Influenza Virus.构建并评价表达 H9N2 禽流感病毒 HA1 蛋白的重组枯草芽孢杆菌的免疫原性。
Curr Microbiol. 2023 Dec 1;81(1):25. doi: 10.1007/s00284-023-03548-x.
7
Current situation and control strategies of H9N2 avian influenza in South Korea.韩国 H9N2 禽流感的现状和控制策略。
J Vet Sci. 2023 Jan;24(1):e5. doi: 10.4142/jvs.22216. Epub 2022 Dec 5.
8
Status and Challenges for Vaccination against Avian H9N2 Influenza Virus in China.中国H9N2亚型禽流感病毒疫苗接种的现状与挑战
Life (Basel). 2022 Aug 27;12(9):1326. doi: 10.3390/life12091326.
9
Protective Efficacy of H9N2 Avian Influenza Vaccines Inactivated by Ionizing Radiation Methods Administered by the Parenteral or Mucosal Routes.电离辐射法灭活的H9N2禽流感疫苗经肠外或黏膜途径接种后的保护效力
Front Vet Sci. 2022 Jul 11;9:916108. doi: 10.3389/fvets.2022.916108. eCollection 2022.
10
Molecular and Antigenic Characterization of Avian H9N2 Viruses in Southern China.中国南方地区禽 H9N2 病毒的分子和抗原特征。
Microbiol Spectr. 2022 Feb 23;10(1):e0082221. doi: 10.1128/spectrum.00822-21. Epub 2022 Jan 12.